Trials / Completed
CompletedNCT00209963
A Study of Gaboxadol in Primary Insomnia
A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 600 (planned)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia.
Detailed description
To obtain long-term safety and tolerability data with gaboxadol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gaboxadol |
Timeline
- Start date
- 2003-06-01
- Completion
- 2005-03-01
- First posted
- 2005-09-21
- Last updated
- 2007-03-30
Source: ClinicalTrials.gov record NCT00209963. Inclusion in this directory is not an endorsement.